𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Strategies to protect the transplanted liver from hepatitis B virus infection

✍ Scribed by Timothy L. Pruett


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
53 KB
Volume
14
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Ganciclovir treatment of hepatitis B vir
✍ R G Gish; J Y Lau; L Brooks; J W S Fang; S L Steady; J C Imperial; R Garcia-Kenn πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 366 KB πŸ‘ 2 views

To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm

Fulminant hepatitis B virus: Recurrence
✍ W A Marsman; R H Wiesner; K P Batts; J J Poterucha; M K Porayko; H G Niesters; P πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 493 KB πŸ‘ 2 views

From the 1 Division of Liver Transplantation and the 2 Division of Pathology, Mayo Clinic lents/mL (geq/mL) as the lowest level of detection. 7

Outcome of patients with hepatitis B vir
✍ Norah A. Terrault; Jonathan T. Carter; Laurie Carlson; Michelle E. Roland; Peter πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 138 KB πŸ‘ 2 views

The outcome of patients with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) referred for liver transplantation (LT) is unknown. A high frequency of lamivudine-resistant (LAM-R) HBV infection may increase the risk of liver-related death pre-transplantation and prophylaxis failure post